Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q2 2021 · 10-Q
Revenue$2.90M$2.90M+5.8% vs Q2 2020 Net Income$98.48K$98.48KN/M vs Q2 2020 EPS Diluted$0.01$0.01N/M vs Q2 2020 Operating Income$103,752N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin3.6%+28.1 pt vs Q2 2020
Net margin3.4%+28.0 pt vs Q2 2020
ended Dec 31, 2020 · filed Feb 16, 2021 · 47 d after period end